Researcher.Life Logo

Blood Coagulation and Fibrinolysis : Impact Factor & More

eISSN: 1473-5733pISSN: 0957-5235

Key Metrics

CiteScore
1.9
Impact Factor
< 5
SJR
Q3Hematology
SNIP
0.6
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Blood Coagulation and Fibrinolysis

Blood Coagulation and Fibrinolysis Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Blood Coagulation and Fibrinolysis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Blood Coagulation and Fibrinolysis

Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence.
  • 15 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Thrombotic thrombocytopenic purpura associated with acalculous cholecystitis masquerading as immune thrombocytopenia.
  • 5 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Fibrin degradation products enhance plasmin activity and contribute to fibrinolysis during simulated trauma-induced coagulopathy.
  • 5 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.
  • 4 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Immune thrombotic thrombocytopenic purpura complicated with Evans syndrome: a case report and literature review.
  • 30 Apr 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Redox-driven antiplatelet effect of snake venom phospholipase A2: VLPLA2 from Vipera lebetina venom as a new antithrombotic agent.
  • 30 Apr 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence.
  • 15 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Thrombotic thrombocytopenic purpura associated with acalculous cholecystitis masquerading as immune thrombocytopenia.
  • 5 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Fibrin degradation products enhance plasmin activity and contribute to fibrinolysis during simulated trauma-induced coagulopathy.
  • 5 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.
  • 4 May 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Immune thrombotic thrombocytopenic purpura complicated with Evans syndrome: a case report and literature review.
  • 30 Apr 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Redox-driven antiplatelet effect of snake venom phospholipase A2: VLPLA2 from Vipera lebetina venom as a new antithrombotic agent.
  • 30 Apr 2026
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

FAQs on Blood Coagulation and Fibrinolysis